Appay, R., Dehais, C., Colin, C., Alentorn, A., Carpentier, C., Ducray, F., . . . Figarella-Branger, D. (2019). PL1.1 CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDHmutant gliomas. Neuro Oncol.
Citação norma ChicagoAppay, R., et al. "PL1.1 CDKN2A Homozygous Deletion Is a Strong Adverse Prognosis Factor in Diffuse Malignant IDHmutant Gliomas." Neuro Oncol 2019.
MLA CitationAppay, R., et al. "PL1.1 CDKN2A Homozygous Deletion Is a Strong Adverse Prognosis Factor in Diffuse Malignant IDHmutant Gliomas." Neuro Oncol 2019.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.